BioInvent, HGSI enter collaboration to co-develop, commercialize therapeutic antibodies
Wednesday, March 17, 2010 15:00 IST Lund, Sweden
BioInvent International AB and Human Genome Sciences, Inc. (HGSI) announced that they have entered into a collaboration to discover, develop and commercialize therapeutic monoclonal antibodies which specifically target